IVF Preparation Checklist for Couples Travelling from Indonesia to China (2026 Guide)

Planning an assisted reproductive journey abroad is a major clinical and emotional milestone. For Indonesian couples seeking advanced in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) at top-tier academic medical centers in Shanghai and Suzhou, thorough pre-travel preparation is essential to optimize stimulation outcomes and avoid unnecessary travel delays.

This comprehensive 2026 preparation checklist outlines the clinical examinations, legal documents, and timeline milestones couples should complete before boarding their flight from Jakarta, Surabaya, Medan, or Bali.

---

1. Pre-Travel Medical Examination Checklist

Before booking flights, our reproductive endocrinologists conduct a remote case review to assess your ovarian reserve and verify clinical eligibility. Having these recent test results (completed within the past 3 to 6 months at a trusted Indonesian laboratory) allows our specialists to design an individualized stimulation protocol prior to your arrival.

For the Female Partner:

• Anti-Müllerian Hormone (AMH): Evaluates baseline ovarian reserve.
• Basal Hormonal Profile (Day 2–3 of cycle): Serum FSH, LH, Estradiol (E2), Progesterone (P), Prolactin (PRL), and Testosterone.
• Transvaginal Pelvic Ultrasound: Antral Follicle Count (AFC) and uterine cavity evaluation (identifying fibroids, polyps, or adenomyosis).
• Tubal Patency Assessment: Hysterosalpingogram (HSG) or hysteroscopy reports if previously performed.
• Thyroid & Metabolic Panel: TSH, FT3, FT4, Fasting Blood Glucose, and HbA1c.
• Infectious Disease Screening: Hepatitis B (HBsAg, HBsAb), Hepatitis C (HCV Ab), HIV I/II, Syphilis (RPR/TPPA).

For the Male Partner:

• Comprehensive Semen Analysis: Following 3–5 days of abstinence (volume, concentration, total motility, progressive motility, and strict Kruger morphology).
• Sperm DNA Fragmentation Index (DFI): Recommended if there is a history of recurrent miscarriage or failed prior cycles.
• Infectious Disease Screening: Hepatitis B, Hepatitis C, HIV, and Syphilis.

---

2. Essential Legal Documents & Visa Support

Assisted reproductive technology (ART) in China is strictly regulated under national healthcare standards to ensure patient safety and ethical compliance.

• Valid Marriage Certificate: Under Chinese regulations, IVF is exclusively provided to legally married heterosexual couples. Couples must present their original marriage certificate (Buku Nikah or Catatan Sipil) along with certified English translation.
• Passports: Valid for at least 6 months beyond your planned date of departure.
• S2 Medical Treatment Visa: OrigCare coordinates with our partner Tier-3A academic hospital centers to issue official hospital invitation letters and medical scheduling confirmations to expedite S2 medical visa processing through Chinese visa application service centers in Jakarta, Surabaya, or Medan.

---

3. Understanding the 12–16 Day In-Country Timeline

A typical fresh IVF cycle with on-site stimulation and fresh embryo transfer requires approximately 12 to 16 days in Shanghai or Suzhou.

Note: If Preimplantation Genetic Testing (PGT-A) or freeze-all strategy is clinically indicated due to ovarian hyperstimulation risk, blastocysts are biopsied and cryopreserved, with frozen embryo transfer (FET) scheduled in a subsequent cycle.

---

4. Transparent Cost Planning & Avoiding Pitfalls

Standard fresh IVF cycles in China range between $6,800 and $11,500 USD (~105M - 180M IDR) at top tertiary academic hospital centers, representing a 45% to 60% savings compared to private hospital alternatives in Singapore.

When comparing overseas clinics, ensure that pricing covers hospital diagnostics, doctor consultations, operating theater fees, and embryology lab culture. Separate fees apply for optional PGT-A genetic screening or long-term embryo cryostorage.

---

5. Ethical Compliance & Medical Transparency

Reputable medical institutions adhere strictly to evidence-based healthcare:

• No Commercial Surrogacy: OrigCare does not arrange, facilitate, or support surrogacy services under any circumstances, adhering strictly to Chinese laws and international medical ethics.
• Honest Clinical Prognosis: In reproductive medicine, clinical outcomes depend on maternal age, AMH, and embryo genetics. Ethical academic centers do not claim "guaranteed success" or "100% pregnancy."
• Continuity of Care in Indonesia: Following your transfer, our bilingual team coordinates with your local Indonesian OB/GYN for ongoing luteal progesterone support and serum beta-hCG pregnancy confirmation.